These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3515527)

  • 21. Etodolac, aspirin, and placebo in patients with rheumatoid arthritis: a 12-week study.
    Edwards W
    Clin Ther; 1983; 5(5):495-503. PubMed ID: 6225520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amiprilose hydrochloride for rheumatoid arthritis.
    Riskin WG; Gillings DB; Scarlett JA
    Ann Intern Med; 1989 Sep; 111(6):455-65. PubMed ID: 2672925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomised, double blind, placebo controlled trial of inosine pranobex in rheumatoid arthritis.
    Brzeski M; Madhok R; Hunter JA; Capell HA
    Ann Rheum Dis; 1990 May; 49(5):293-5. PubMed ID: 1693065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Double-blind crossover study to evaluate the efficacy of a single daily dose of naproxen in rheumatoid arthritis.
    Katona G; Vargas RB
    Eur J Rheumatol Inflamm; 1983; 6(3):233-41. PubMed ID: 6391928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low-dose D-penicillamine therapy in rheumatoid arthritis. A controlled, double-blind clinical trial.
    Williams HJ; Ward JR; Reading JC; Egger MJ; Grandone JT; Samuelson CO; Furst DE; Sullivan JM; Watson MA; Guttadauria M; Cathcart ES; Kaplan SB; Halla JT; Weinstein A; Plotz PH
    Arthritis Rheum; 1983 May; 26(5):581-92. PubMed ID: 6342625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Novel Highly Bioavailable Curcumin Formulation Improves Symptoms and Diagnostic Indicators in Rheumatoid Arthritis Patients: A Randomized, Double-Blind, Placebo-Controlled, Two-Dose, Three-Arm, and Parallel-Group Study.
    Amalraj A; Varma K; Jacob J; Divya C; Kunnumakkara AB; Stohs SJ; Gopi S
    J Med Food; 2017 Oct; 20(10):1022-1030. PubMed ID: 28850308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intra-articular rimexolone in the rheumatoid knee: a placebo-controlled, double-blind, multicentre trial of three doses.
    van Vliet-Daskalopoulou E; Jentjens T; Scheffer RT
    Br J Rheumatol; 1987 Dec; 26(6):450-3. PubMed ID: 3318993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects: a randomized, double-blind, placebo-controlled clinical trial.
    van Everdingen AA; Jacobs JW; Siewertsz Van Reesema DR; Bijlsma JW
    Ann Intern Med; 2002 Jan; 136(1):1-12. PubMed ID: 11777359
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tolmetin sodium, a new anti-arthritis drug: double-blind and long-term studies.
    Cordrey LJ
    J Am Geriatr Soc; 1976 Oct; 24(10):440-6. PubMed ID: 61224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Seatone in rheumatoid arthritis: a six-month placebo-controlled study.
    Larkin JG; Capell HA; Sturrock RD
    Ann Rheum Dis; 1985 Mar; 44(3):199-201. PubMed ID: 3883918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A double-blind comparison of phenylbutazone and suxibuzone, a prodrug of phenylbutazone, in rheumatoid arthritis.
    Mizushima Y; Shiokawa Y; Honma M; Kageyama T
    Int J Tissue React; 1983; 5(1):35-9. PubMed ID: 6345427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparative study of isoxicam and naproxen in rheumatoid arthritis.
    Schorn D
    S Afr Med J; 1985 Mar; 67(12):452-4. PubMed ID: 3885424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sulfasalazine in rheumatoid arthritis. A double-blind, placebo-controlled trial.
    Pinals RS; Kaplan SB; Lawson JG; Hepburn B
    Arthritis Rheum; 1986 Dec; 29(12):1427-34. PubMed ID: 2879544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial. MIRA Trial Group.
    Tilley BC; Alarcón GS; Heyse SP; Trentham DE; Neuner R; Kaplan DA; Clegg DO; Leisen JC; Buckley L; Cooper SM; Duncan H; Pillemer SR; Tuttleman M; Fowler SE
    Ann Intern Med; 1995 Jan; 122(2):81-9. PubMed ID: 7993000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of nabumetone in the treatment of active adult rheumatoid arthritis.
    Lanier BG; Turner RA; Collins RL; Senter RG
    Am J Med; 1987 Oct; 83(4B):40-3. PubMed ID: 3318427
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diclofenac (Voltarol) in rheumatoid arthritis: a report of a double-blind trial.
    Doreen MS; Boardman PL; Fowler PD; Poole PH
    Rheumatol Rehabil; 1979; Suppl 2():78-80. PubMed ID: 394280
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of sirukumab in patients with active rheumatoid arthritis refractory to anti-TNF therapy (SIRROUND-T): a randomised, double-blind, placebo-controlled, parallel-group, multinational, phase 3 study.
    Aletaha D; Bingham CO; Tanaka Y; Agarwal P; Kurrasch R; Tak PP; Popik S
    Lancet; 2017 Mar; 389(10075):1206-1217. PubMed ID: 28215362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparative study of fenbufen and indomethacin in patients with rheumatoid arthritis.
    Deodhar SD; Sethi R
    Curr Med Res Opin; 1979; 6(4):263-6. PubMed ID: 393464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclosporin in rheumatoid arthritis: a double blind, placebo controlled study in 52 patients.
    Dougados M; Awada H; Amor B
    Ann Rheum Dis; 1988 Feb; 47(2):127-33. PubMed ID: 3281603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxaprozin and sulindac in rheumatoid arthritis: a double-blind comparative trial.
    Zuccollo R; Mackinnon MJ; Fraser KM; Hall SM; Palmer DG
    Curr Med Res Opin; 1983; 8(5):302-9. PubMed ID: 6340971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.